Processa Pharmaceuticals's total assets for Q3 2024 were $4.94M, a decrease of -34.98% from the previous quarter. PCSA total liabilities were $1.22M for the fiscal quarter, a -22.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.